Efficacy and safety of first-line immunotherapy for advanced gastric or gastroesophageal cancer: System review network meta-analysis

被引:0
|
作者
Qin, Qiong
Sun, Yongkun
Yang, Lin
Zhong, Diansheng
机构
[1] Tianjin Med Univ, Gen Hosp, Tianjin, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Dept Med Oncol, Natl Canc Ctr, Natl Clin Res Ctr Canc,Canc Hosp, Beijing, Peoples R China
[3] Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Natl Clin Res Ctr Canc, Canc Hosp, Beijing, Peoples R China
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e16014
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Efficacy and Safety of First-Line Immunotherapy Combinations for Advanced NSCLC: A Systematic Review and Network Meta-Analysis
    Liu, Lihui
    Bai, Hua
    Wang, Chao
    Seery, Samuel
    Wang, Zhijie
    Duan, Jianchun
    Li, Sini
    Xue, Pei
    Wang, Guoqiang
    Sun, Yiting
    Du, Xinyang
    Zhang, Xue
    Ma, Zixiao
    Wang, Jie
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (07) : 1099 - 1117
  • [2] The Efficacy and Safety of First-line Chemotherapy in Advanced Esophagogastric Cancer: A Network Meta-analysis
    ter Veer, Emil
    Mohammad, Nadia Haj
    van Valkenhoef, Gert
    Ngai, Lok Lam
    Mali, Rosa M. A.
    Anderegg, Maarten C.
    van Oijen, Martijn G. H.
    van Laarhoven, Hanneke W. M.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2016, 108 (10):
  • [3] The Efficacy and Safety of First-line Chemotherapies for Advanced Biliary Tract Cancer: A Network Meta-analysis
    Zheng, Wei
    Ying, Jie
    Zhou, Yan
    Lu, Zhiwen
    Min, Ke
    Wang, Weimin
    Zhang, Yun
    Zhang, Miao
    Yang, Jian
    JOURNAL OF CANCER, 2019, 10 (01): : 257 - +
  • [4] First-line systemic therapy for advanced gastric cancer: a systematic review and network meta-analysis
    Cheng, Ji
    Cai, Ming
    Shuai, Xiaoming
    Gao, Jinbo
    Wang, Guobin
    Tao, Kaixiong
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2019, 11
  • [5] Efficacy and safety of immunochemotherapy, immunotherapy, chemotherapy, and targeted therapy as first-line treatment for advanced and metastatic esophageal cancer: a systematic review and network meta-analysis
    Gao, Zhen
    Huang, Shujie
    Wang, Sichao
    Tang, Dezhao
    Xu, Wei
    Zeng, Ruijie
    Qiao, Guibin
    LANCET REGIONAL HEALTH-WESTERN PACIFIC, 2023, 38
  • [6] Comparative efficacy and tolerability of targeted and immunotherapy combined with chemotherapy as first-line treatment for advanced gastric cancer: a Bayesian network meta-analysis
    Shu Liu
    Heung Yan Wong
    Li Xie
    Yoojin Kim
    Danhua Shu
    Beishi Zheng
    Naxin Liu
    Chungen Xing
    Xiaolei Chen
    Qiantong Dong
    Scientific Reports, 12
  • [7] Comparative efficacy and tolerability of targeted and immunotherapy combined with chemotherapy as first-line treatment for advanced gastric cancer: a Bayesian network meta-analysis
    Liu, Shu
    Wong, Heung Yan
    Xie, Li
    Kim, Yoojin
    Shu, Danhua
    Zheng, Beishi
    Liu, Naxin
    Xing, Chungen
    Chen, Xiaolei
    Dong, Qiantong
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [8] Efficacy and Safety of First-line Therapies for Advanced Unresectable Oesophageal Squamous Cell Cancer: a Systematic Review and Network Meta-analysis
    Nian, Z.
    Zhao, Q.
    He, Y.
    Xie, R.
    Liu, W.
    Chen, T.
    Huang, S.
    Dong, L.
    Huang, R.
    Yang, L.
    CLINICAL ONCOLOGY, 2024, 36 (01) : 30 - 38
  • [9] Efficacy and safety of pembrolizumab in advanced gastric and gastroesophageal junction cancer: a systematic review and meta-analysis
    Xiaoying Ji
    Guoping Wang
    Dandan Pan
    Shanxia Xu
    Xinming Lei
    BMC Gastroenterology, 25 (1)
  • [10] Efficacy of PD-1 inhibitors in first-line treatment for advanced gastroesophageal junction and gastric cancer by subgroups: A systematic review and meta-analysis
    Fei, Shengqi
    Lu, Yu
    Chen, Jing
    Qi, Jia
    Wu, Wenxuan
    Wang, Beidi
    Han, Yaxuan
    Wang, Kefan
    Han, Xiaying
    Zhou, Haiyan
    Wang, Jun
    Chen, Jian
    CHEMOTHERAPY, 2023, 68 (04) : 197 - 209